Abstract Submission Deadline:
Thursday, September 10
- SUBMIT ABSTRACT
(available in mid-late July)
- ABSTRACT CATEGORIES
(available in mid-late July)
- CONTACT US
|
|
CONTENT OF ABSTRACTS
Authors who submit abstracts confirm that they have not previously published these data, that they have not previously presented them at a large national annual scientific meeting, and that they are not planning to present or publish them prior to the dates of the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference (November 15-19, 2009).
Members of the Scientific Committee will evaluate the quality of the submitted abstracts on the basis of the following criteria: novelty of the research, significance of the findings, and clarity. Authors should be particularly cognizant of the importance of setting forth the objectives and hypotheses of the study in a clear, succinct manner and of summarizing the new, unpublished results. If the abstract is poorly written such that the Scientific Committee cannot determine its novelty and importance, the paper will not be accepted for presentation at the conference.
Each abstract should contain: (a) an introductory sentence indicating the purposes of the study; (b) a brief description of pertinent experimental procedures; (c) a summary of the new, unpublished data; and (d) a statement of the conclusions.
Authors must accept sole responsibility for the statements in their abstracts. Abstracts should be carefully proofread to avoid errors in the published literature. American spelling should be used throughout. For more information regarding American spelling, please refer to Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers, Seventh Edition (Council of Science Editors, 2006).
SUBMISSION PROCEDURE
AACR Online Abstract Submission System
Authors must submit abstracts for presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference using the AACR Online Abstract Submission System. The Online Abstract Submission System will be available in late June / early July. Authors who have not used the AACR Online Abstract Submission System will be required to register with the site to create a user profile. After creating a profile, an author can create, modify, and submit an abstract until the September 10 deadline. If you have used the system before and need assistance with your username or password, please contact Customer Service at (217) 398-1792 or support@abstractsonline.com.
Note Regarding Internet Browsers
To optimize the performance of the Online Abstract Submission System, authors are strongly encouraged to upgrade their Internet browser to Microsoft Internet Explorer version 6.0 or higher. If necessary, users can link from the Online Abstract Submission System Help window to a download site to obtain an appropriate version of their browser. Users should be sure that their browsers are set to enable JavaScript and to accept cookies. Users who need assistance in properly updating and configuring their browsers should contact Customer Service at (217) 398-1792 or support@abstractsonline.com.
Abstract Control Number
An Abstract Control Number will be assigned to each abstract submitted through the Online Abstract Submission System. This number will be displayed at the top of the submitter screen and will be listed on all e-mail correspondence regarding the abstract. Please refer to the Abstract Control Number in any subsequent abstract communications.
Length of Abstracts
The combined length of the abstract body, title, and tables may not exceed 2,600 characters. Spaces and the author string are not counted against the character limit. Tables will count for 800 characters against the limit. The Online Abstract Submission System will not accept abstracts that exceed this limit.
Submission of Abstracts/Confirmation of Receipt
Presenters are strongly encouraged to print a copy of their abstract for their records before submitting. At the time of submission, authors can request that a confirmation of receipt be e-mailed to the corresponding author at the address provided in the Online Abstract Submission System. In addition, once the abstract deadline has passed a confirmation of receipt will be sent to the presenting authors of all valid abstracts.
Note
The e-mailed confirmation of receipt is not a notice of acceptance of the abstract for presentation at the 2009 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics conference. Notifications of abstract status will be sent in early October, 2009.
Accuracy of Abstracts
The accuracy of the submitted abstract is the responsibility of the authors. Although abstracts will be typeset for print and electronic distribution, they will not be edited for typographical errors or corrected by AACR staff except as needed to conform to publication style. Therefore, authors should carefully prepare and proofread their abstracts prior to submission.
If you have completed an abstract submission, you may log in and edit the abstract as often as you wish until the September 10 abstract deadline. However, once abstract submission has closed, no more changes to the abstracts will be accepted.
DISCLOSURE OF CHEMICAL STRUCTURES
At the time of abstract submission, the abstract submitter is required to state whether chemical compounds were used in the scientific work to generate the data in the proffered paper. Chemical compounds are defined as low molecular weight (generally <1000 g/mol) organic or inorganic molecules, peptides, or proteins/nucleic acids cocrystallized with low molecular weight molecules. If chemical compounds were used, the abstract submitter is further required to indicate whether the complete chemical structures of the compounds used will be disclosed at the time of presentation at the conference. The chemical structures are not required to be included at the time of abstract submission; rather, indication of the intent to disclose any such structures at the time of presentation is required.
The Scientific Committee will then evaluate the information provided by the abstract submitter and determine the acceptability of the proffered paper for presentation. Those who do not intend to disclose chemical structures may have their abstracts rejected for participation; however, a limited number of these abstracts may be accepted for presentation if deemed to be of sufficient scientific merit.